Business Description
HeiLongJiang ZBD Pharmaceutical Co Ltd
SIC : 2834
ISIN : CNE100002219
Share Class Description:
SHSE:603567: Class ATotal Employee Number:
1,961Compare
Compare
Traded in other countries / regions
603567.China Index Membership
SSE Composite Index IPO Date
2015-04-24Description
HeiLongJiang ZBD Pharmaceutical Co Ltd is a China-based pharmaceutical company engaged in the research, development, production, and sale of traditional Chinese medicine and related healthcare products. Its business spans the manufacture and distribution of traditional Chinese medicine decoction pieces, Chinese medicine formula granules, and Chinese herbal medicines, along with wholesale and retail operations. The company also trades in medical equipment and sanitary materials and provides inspection and testing services. Its customers include hospitals, clinics, pharmacies, and other healthcare institutions across China, with distribution networks covering multiple provinces. Revenue is generated primarily through the sale of pharmaceutical and herbal medicine products, supplemented by trading activities and testing services. The company operates mainly within the domestic Chinese market, where demand for traditional Chinese medicine and formula granules forms the core of its business.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.52 | |||||
Debt-to-EBITDA | -1.83 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.63 | |||||
Beneish M-Score | -3.12 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -42.6 | |||||
3-Year EPS without NRI Growth Rate | -70.2 | |||||
3-Year Book Growth Rate | -4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 40.71 | |||||
9-Day RSI | 39.24 | |||||
14-Day RSI | 41.41 | |||||
3-1 Month Momentum % | 33.33 | |||||
6-1 Month Momentum % | -14.99 | |||||
12-1 Month Momentum % | -46.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.32 | |||||
Quick Ratio | 0.96 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 694.46 | |||||
Days Sales Outstanding | 2636.83 | |||||
Days Payable | 159.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.68 | |||||
3-Year Dividend Growth Rate | 12.3 | |||||
5-Year Yield-on-Cost % | 2.68 | |||||
Shareholder Yield % | 7.05 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -98.02 | |||||
Operating Margin % | -181.61 | |||||
Net Margin % | -410.66 | |||||
EBITDA Margin % | -452.37 | |||||
FCF Margin % | 116.62 | |||||
OCF Margin % | 127.89 | |||||
ROE % | -23.34 | |||||
ROA % | -14.04 | |||||
ROIC % | -5.72 | |||||
3-Year ROIIC % | -229.28 | |||||
ROC (Joel Greenblatt) % | -33.41 | |||||
ROCE % | -23.22 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 6.94 | |||||
Shiller PE Ratio | 21.19 | |||||
PS Ratio | 13.66 | |||||
PB Ratio | 0.86 | |||||
Price-to-Tangible-Book | 1.09 | |||||
Price-to-Free-Cash-Flow | 11.63 | |||||
Price-to-Operating-Cash-Flow | 10.58 | |||||
EV-to-EBIT | -14.62 | |||||
EV-to-EBITDA | -19.77 | |||||
EV-to-Revenue | 21.86 | |||||
EV-to-FCF | 18.75 | |||||
Price-to-GF-Value | 3.7 | |||||
Price-to-Projected-FCF | 6.8 | |||||
Price-to-Median-PS-Value | 3.8 | |||||
| Price-to-Net-Current-Asset-Value | 9.03 | |||||
Earnings Yield (Greenblatt) % | -6.84 | |||||
FCF Yield % | 8.54 | |||||
Forward Rate of Return (Yacktman) % | -29.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HeiLongJiang ZBD Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 379.577 | ||
| EPS (TTM) (Â¥) | -1.66 | ||
| Beta | 0.3507 | ||
| 3-Year Sharpe Ratio | -0.53 | ||
| 3-Year Sortino Ratio | -0.71 | ||
| Volatility % | 62.04 | ||
| 14-Day RSI | 41.41 | ||
| 14-Day ATR (Â¥) | 0.277423 | ||
| 20-Day SMA (Â¥) | 5.5165 | ||
| 12-1 Month Momentum % | -46.71 | ||
| 52-Week Range (Â¥) | 4.21 - 12.3 | ||
| Shares Outstanding (Mil) | 940.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HeiLongJiang ZBD Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HeiLongJiang ZBD Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.150000 Cash Dividend | 2025-08-20 | 12.44 (-1.27%) | ||
| 2:1 Stock Split | 2016-06-13 | 25.00 (-1.98%) |
Show
Entries
HeiLongJiang ZBD Pharmaceutical Co Ltd Frequently Asked Questions
What is HeiLongJiang ZBD Pharmaceutical Co Ltd(SHSE:603567)'s stock price today?
The current price of SHSE:603567 is ¥5.51. The 52 week high of SHSE:603567 is ¥12.30 and 52 week low is ¥4.21.
When is next earnings date of HeiLongJiang ZBD Pharmaceutical Co Ltd(SHSE:603567)?
The next earnings date of HeiLongJiang ZBD Pharmaceutical Co Ltd(SHSE:603567) is .
Does HeiLongJiang ZBD Pharmaceutical Co Ltd(SHSE:603567) pay dividends? If so, how much?
The Dividend Yield %  of HeiLongJiang ZBD Pharmaceutical Co Ltd(SHSE:603567) is 2.68% (As of Today), Highest Dividend Payout Ratio of HeiLongJiang ZBD Pharmaceutical Co Ltd(SHSE:603567) was 0.6. The lowest was 0.06. And the median was 0.44. The  Forward Dividend Yield % of HeiLongJiang ZBD Pharmaceutical Co Ltd(SHSE:603567) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers